Leslie Leinwand
Compliance Officer chez FULCRUM THERAPEUTICS, INC.
Profil
Leslie Leinwand was the founder of MyoKardia, Inc. (2012) and Hiberna Corp.
(2006), where she held the title of Director.
She is also the founder of Gilead Colorado, Inc. Dr. Leinwand's current jobs include serving on the Board of Directors for Global Down Syndrome Foundation, being a Professor at Howard Hughes Medical Institute, Inc., serving as Chief Scientific Officer & Professor at The University of Colorado, and being on the Scientific Advisory Boards for Linda Crnic Institute for Down Syndrome, TARA Biosystems, Inc., Fulcrum Therapeutics, Inc., Edgewise Therapeutics, Inc., and Catalio Capital Management LP as a Venture Partner.
Her former job was as a Faculty Member at Albert Einstein College of Medicine, Inc. Dr. Leinwand received her doctorate from Yale University and her undergraduate degree from Cornell University.
Postes actifs de Leslie Leinwand
| Sociétés | Poste | Début |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Consultant / Advisor | - |
| FULCRUM THERAPEUTICS, INC. | Compliance Officer | - |
| The University of Colorado | Chief Tech/Sci/R&D Officer | - |
| Global Down Syndrome Foundation | Director/Board Member | - |
| Linda Crnic Institute for Down Syndrome | Consultant / Advisor | - |
TARA Biosystems, Inc.
 TARA Biosystems, Inc. Packaged SoftwareTechnology Services TARA Biosystems, Inc. develops organ-on-a-chip platform. It focuses on cardiac toxicology, heart failure drug discovery and personalized cardiology. The company was founded by Misti Ushio, Milica Radisic, Yimu Zhao, Gordana Vunjak-Novakovic, Kacey Ronaldson, Boyang Zhang and Blake Stevens on October 22, 2014 and is headquartered in New York, NY. | Consultant / Advisor | - |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Corporate Officer/Principal | - |
Anciens postes connus de Leslie Leinwand
| Sociétés | Poste | Fin |
|---|---|---|
Hiberna Corp.
 Hiberna Corp. Drugstore ChainsRetail Trade Hiberna Corp. provides organic drugs. The company was founded by Gordon van Dusen, Leslie Leinwand, Sandy Martin and Thomas G. Marr in 2006 and is headquartered in Boulder, CO. | Founder | - |
| ░░░░░░ ░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Formation de Leslie Leinwand
| Yale University | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| EDGEWISE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Health Technology |
Hiberna Corp.
Hiberna Corp. Drugstore ChainsRetail Trade Hiberna Corp. provides organic drugs. The company was founded by Gordon van Dusen, Leslie Leinwand, Sandy Martin and Thomas G. Marr in 2006 and is headquartered in Boulder, CO. | Retail Trade |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Miscellaneous |
| Global Down Syndrome Foundation | |
TARA Biosystems, Inc.
TARA Biosystems, Inc. Packaged SoftwareTechnology Services TARA Biosystems, Inc. develops organ-on-a-chip platform. It focuses on cardiac toxicology, heart failure drug discovery and personalized cardiology. The company was founded by Misti Ushio, Milica Radisic, Yimu Zhao, Gordana Vunjak-Novakovic, Kacey Ronaldson, Boyang Zhang and Blake Stevens on October 22, 2014 and is headquartered in New York, NY. | Technology Services |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
